Hodgkin Disease
Showing 1 - 25 of 91
Hodgkin Disease Trial in France (Morphological and functional magnetic resonance imaging (MRI), Neuropsychological assessment)
Not yet recruiting
- Hodgkin Disease
- Morphological and functional magnetic resonance imaging (MRI)
- Neuropsychological assessment
-
Arras, France
- +3 more
Oct 31, 2023
Acute Lymphoblastic Leukemia, Hodgkin Disease, Allogeneic Stem Cell Transplantation Trial in Erlangen (Low-field magnetic
Recruiting
- Acute Lymphoblastic Leukemia
- +2 more
- Low-field magnetic resonance imaging
- +3 more
-
Erlangen, Bavaria, GermanyDepartment of Pediatrics and Adolescent Medicine
Oct 23, 2023
Clinical, Laboratory and Epidemiologic Characterization of
Recruiting
- Waldenstrom Macroglobulinemia
- +4 more
-
Bethesda, Maryland
- +1 more
Jan 25, 2023
Resting Heart Rate and Heart Rate Variability in Survivors of
Active, not recruiting
- Hodgkin Disease
-
Memphis, TennesseeKirsten Ness
Jan 23, 2023
Hodgkin Disease, Non-Hodgkin Lymphoma, Severe Chronic Active Epstein Barr Virus Trial in Houston (MABEL CTLs, Cyclophosphamide,
Recruiting
- Hodgkin Disease
- +5 more
- MABEL CTLs
- +2 more
-
Houston, Texas
- +1 more
Jan 13, 2023
Multiple Myeloma, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Charlottesville (Pre-biotic foods/drinks)
Completed
- Multiple Myeloma
- +11 more
- Pre-biotic foods/drinks
-
Charlottesville, VirginiaUniversity of Virginia
Jan 2, 2023
Patterns and Disease Control in cHL and sALCL in Routine
Completed
- Hodgkin Disease
- Lymphoma, Large-cell, Anaplastic
-
Astrakhan, Russian Federation
- +49 more
Dec 19, 2022
Breast Tumor, Prostatic Tumor, Colorectal Tumors Trial in United States (AH-HA Tool in the EPIC EHR)
Enrolling by invitation
- Breast Neoplasm
- +5 more
- AH-HA Tool in the EPIC EHR
-
Fort Smith, Arkansas
- +11 more
Dec 8, 2022
Pediatric Cancer, Hodgkin Disease, CD30-Positive DLBCL Trial in Milwaukee (anti-CD30 Bispecific Antibody-armed
Not yet recruiting
- Pediatric Cancer
- +11 more
- anti-CD30 Bispecific Antibody-armed anti-CD3-Activated Autologous T-cells (CD30 biAb-AATC)
-
Milwaukee, WisconsinChildren's Wisconsin
Sep 14, 2022
Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, MDS Trial in Saint Louis (procedure, drug, other)
Recruiting
- Acute Myelogenous Leukemia
- +4 more
- Stem cell transplantation
- +3 more
-
Saint Louis, MissouriWashington University School of Medicine
Aug 23, 2022
Hodgkin Disease, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell Trial in Worldwide (pembrolizumab, Favezelimab)
Recruiting
- Hodgkin Disease
- +2 more
- pembrolizumab
- Favezelimab
-
Gilbert, Arizona
- +24 more
Aug 18, 2022
Lymphoma, Non-Hodgkin, Hodgkin Disease Trial in Worldwide (Relatlimab, Nivolumab)
Not yet recruiting
- Lymphoma, Non-Hodgkin
- Hodgkin Disease
-
Phoenix, Arizona
- +53 more
Aug 17, 2022
Lung Cancer, Esophageal Cancer, Thoracic Cancer Trial in Saint Louis (Home-based cardiac rehabilitation)
Recruiting
- Lung Cancer
- +8 more
- Home-based cardiac rehabilitation
-
Saint Louis, MissouriWashington University School of Medicine
Aug 9, 2022
Relapsed or Refractory CD30+ Malignancies When Re-treated With
Completed
- Hodgkin Disease
- Lymphoma, T-Cell, Cutaneous
- No Intervention
-
San Bartolome, Alicante, Spain
- +29 more
Jul 28, 2022
Hodgkin Disease Trial in Worldwide (Nivolumab, brentuximab vedotin, bendamustine)
Active, not recruiting
- Hodgkin Disease
- Nivolumab
- +2 more
-
Birmingham, Alabama
- +77 more
Jul 21, 2022
Biospecimen Procurement for Center for Immuno-Oncology
Recruiting
- Multiple Myeloma
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 13, 2022
Hodgkin Disease Trial in Worldwide (Brentuximab vedotin, Doxorubicin, Vinblastine)
Completed
- Hodgkin Disease
- Brentuximab vedotin
- +3 more
-
Aurora, Colorado
- +13 more
Jun 17, 2022
Brazilian Prospective Hodgkin Lymphoma Registry
Recruiting
- Hodgkin Lymphoma
- Hodgkin Disease
-
Rio de Janeiro, BrazilUniversidade Federal Do Rio de Janeiro
May 16, 2022
Young Adults, Lymphoma, Non-Hodgkin, Hodgkin Disease Trial in Clermont-Ferrand (Indirect calorimetric test during submaximal
Recruiting
- Young Adults
- +2 more
- Indirect calorimetric test during submaximal exercise
-
Clermont-Ferrand, FranceCHU de Clermont-Ferrand
May 3, 2022
Late Effects, Testicular Germ Cell Tumor Mixed, Non-Metastatic Breast Carcinoma Trial in Lyon (PASCA intervention)
Recruiting
- Late Effects
- +8 more
- PASCA intervention
-
Lyon, FranceCentre Leon Berard
Mar 15, 2022
Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin Trial in Chapel Hill, Winston-Salem (ATLCAR.CD30 cells)
Active, not recruiting
- Hodgkin Disease
- +8 more
- ATLCAR.CD30 cells
-
Chapel Hill, North Carolina
- +1 more
Mar 2, 2022
Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia Trial in Atlanta, Saint Louis, Columbus
Active, not recruiting
- Acute Myelogenous Leukemia
- +10 more
- BL-8040
- +2 more
-
Atlanta, Georgia
- +2 more
Feb 9, 2022
Hodgkin Disease Trial in Belgium, France (Brentuximab Vedotin, Etoposide, Carboplatine)
Completed
- Hodgkin Disease
- Brentuximab Vedotin
- +3 more
-
Bruxelles, Belgium
- +18 more
Dec 6, 2021